Your search returned 5 results.

Results
	1.	Results of a prospective phase 2 study of pazopanib in patients with advanced intermediate-grade or high-grade liposarcoma. MedStar authors: Priebat, Dennis A PMID: 28832986 Year: 2017 Citation: Cancer. 123(23):4640-4647, 2017 Dec 01 Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Chawla SP, Kaiser PE, Milhem MM, Portnoy DC, Priebat DA, Samuels BL, Skubitz KM, Somaiah N, Staddon AP, Stepanski EJ, Walker MS DOI: https://dx.doi.org/10.1002/cncr.30926 Add to cart (remove)
	2.	Recurrent erythematous plaques on sun-exposed sites in an African American boy with chronic granulomatous disease. MedStar authors: Turegano, Mamina M PMID: 24528905 Year: 2014 Citation: Journal of the American Academy of Dermatology. 70(3):576-80, 2014 Mar. Institution: MedStar Washington Hospital Center Department: Medicine/Dermatology Medline publication type: Case Reports Journal Article Research Support, N.I.H., Intramural Form of publication: Journal Article All authors: Brownell I, Cowen EW, De Ravin SS, Lee CC, Malech HL, Turegano MM DOI: http://dx.doi.org/10.1016/j.jaad.2013.09.051 Add to cart (remove)
	3.	Phase I trial of dasatinib and ixabepilone in patients with solid tumors. MedStar authors: Herbolsheimer, Pia M Jelinek, James S Kapoor, R Perry, David J Smith, Karen L Swain, Sandra M Verma, Nitin Veytsman, Irina PMID: 22392508 Citation: Investigational New Drugs. 31(1):92-8, 2013 Feb. Institution: MedStar Washington Hospital Center Washington Cancer Institute Department: Radiology Medline publication type: Clinical Trial, Phase I Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Herbolsheimer P, Jelinek J, Kapoor R, Perry D, Smith KL, Swain SM, Verma N, Veytsman I DOI: http://dx.doi.org/10.1007/s10637-012-9805-y Add to cart (remove)
	4.	Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial. MedStar authors: Brewer, H Bryan PMID: 26047975 Year: 2015 Citation: Lancet. 386(9992):452-60, 2015 Aug 1. Institution: MedStar Health Research Institute Medline publication type: Clinical Trial, Phase II Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Barter PJ, Brewer HB, Ford J, Hovingh GK, Kastelein JJ, Rader DJ, Round P, Saleheen D, van Deventer SJ DOI: http://dx.doi.org/10.1016/S0140-6736(15)60158-1 Add to cart (remove)
	5.	A phase 1 study of lenalidomide and ibrutinib in combination with rituximab in relapsed and refractory CLL. MedStar authors: Trivedi, Neel PMID: 29610115 Year: 2018 Citation: Blood Advances. 2(7):762-768, 2018 Apr 10 Institution: MedStar Washington Hospital Center Department: Hematology and Oncology Medline publication type: Journal Article Form of publication: Journal Article All authors: Cheson BD, Khan N, Ramzi P, Skarbnik A, Trivedi N, Ujjani C, Wang H DOI: https://dx.doi.org/10.1182/bloodadvances.2017015263 Add to cart (remove)

Powered by Koha